Flowserve (NYSE: FLS) CEO reports major equity grants and vesting
Rhea-AI Filing Summary
Flowserve Corporation’s President and CEO Robert Scott Rowe reported multiple equity compensation transactions. On February 12, 2026, he received grants of 57,034 performance rights and 38,022 restricted stock units, each representing a contingent right to one share of common stock at vesting.
The new performance rights for the 2026–2028 cycle vest between 0% and 200% based on return on invested capital and average annual earnings-per-share growth, with a 15% total shareholder return modifier versus the S&P 500 Industrial Index. The restricted stock units vest ratably over three years starting March 1, 2026.
On February 13, 2026, 184,264 performance rights from a 2023–2025 cycle were exercised into common stock, increasing Rowe’s directly held common stock by 194,460 shares at a stated price of $0. In a related tax-withholding transaction, 76,522 shares were disposed of at $87.02 per share, leaving him with 464,652 directly owned common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 184,264 | $0.00 | -- |
| Grant/Award | Common Stock | 194,460 | $0.00 | -- |
| Tax Withholding | Common Stock | 76,522 | $87.02 | $6.66M |
| Grant/Award | Performance Rights | 57,034 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 38,022 | $0.00 | -- |
Footnotes (1)
- Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2023 and ending on December 31, 2025 which are based equally on: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of adjusted net income for each calendar year during the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.